These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1453292)

  • 1. In vitro lymphocyte functions in the presence of bovine surfactant and its phospholipid fractions.
    Bartmann P; Gortner L; Pohlandt F; Jaeger H
    J Perinat Med; 1992; 20(3):189-96. PubMed ID: 1453292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of three surfactant preparations on in vitro lymphocyte functions.
    Woerndle S; Bartmann P
    J Perinat Med; 1994; 22(2):119-28. PubMed ID: 7965541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and immunomodulatory activity of bovine surfactant (SF-RI 1).
    Bartmann P; Bamberger U; Pohlandt F; Gortner L
    Acta Paediatr; 1992 May; 81(5):383-8. PubMed ID: 1498502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of concanavalin A, phytohemagglutinin, pokeweed mitogen, and lipopolysaccharide on the replication and immunoglobulin synthesis by canine peripheral blood lymphocytes in vitro.
    Letwin BW; Quimby FW
    Immunol Lett; 1987 Jan; 14(2):79-85. PubMed ID: 3583319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of immune functions by human surfactant.
    Shimizu M; Vayuvegula B; Ellis M; Gluck L; Gupta S
    Ann Allergy; 1988 Dec; 61(6):459-62. PubMed ID: 2974258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro.
    Kremlev SG; Umstead TM; Phelps DS
    Am J Physiol; 1994 Oct; 267(4 Pt 1):L357-64. PubMed ID: 7943339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of multilamellar phospholipid vesicles with bovine lymphocytes: effects of alpha-tocopherol on lymphocyte blastogenesis.
    Fountain MW; Dees C; Weete JD; Schultz RD
    Mol Immunol; 1982 Nov; 19(11):1491-8. PubMed ID: 6897850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes.
    Wilsher ML; Hughes DA; Haslam PL
    Thorax; 1988 May; 43(5):354-9. PubMed ID: 3194863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant.
    Ernst N; Ulrichskötter S; Schmalix WA; Rädler J; Galneder R; Mayer E; Gersting S; Plank C; Reinhardt D; Rosenecker J
    J Gene Med; 1999; 1(5):331-40. PubMed ID: 10738550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of lymphocyte modulatory control by surfactant lipid extracts from acute hypersensitivity pneumonitis: comparison with sarcoidosis and idiopathic pulmonary fibrosis.
    Lesur O; Mancini NM; Janot C; Chabot F; Boitout A; Polu JM; Gérard H
    Eur Respir J; 1994 Nov; 7(11):1944-9. PubMed ID: 7875263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemiluminescence activity of phagocytes from tracheal aspirates of premature infants after surfactant therapy.
    Schrod L; Hornemann F; von Stockhausen HB
    Acta Paediatr; 1996 Jun; 85(6):719-23. PubMed ID: 8816211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host defence capacities of pulmonary surfactant: evidence for 'non-surfactant' functions of the surfactant system.
    Pison U; Max M; Neuendank A; Weissbach S; Pietschmann S
    Eur J Clin Invest; 1994 Sep; 24(9):586-99. PubMed ID: 7828630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
    Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
    Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lymphocyte reactivity after in vitro exposure to technical and analytical grade pentachlorophenol.
    Lang D; Mueller-Ruchholtz W
    Toxicology; 1991; 70(3):271-82. PubMed ID: 1771635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological aberration in primary hyperparathyroidism.
    Elias AN; Sharma BS; Stokes JD; Valenta LJ
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):47-50. PubMed ID: 6981907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile.
    Wilsher ML; Hughes DA; Haslam PL
    Clin Exp Immunol; 1988 Jul; 73(1):117-22. PubMed ID: 3168326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of modified natural and synthetic surfactant preparations on bacterial killing by polymorphonuclear leucocytes.
    Rauprich P; Walter G; Jarstrand C; Robertson B; Herting E
    Immunobiology; 2004; 209(8):609-17. PubMed ID: 15638129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome.
    Griese M; Dietrich P; Reinhardt D
    Am J Respir Crit Care Med; 1995 Sep; 152(3):1050-4. PubMed ID: 7663782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injury.
    Häfner D; Germann PG; Hauschke D; Kilian U
    Pulm Pharmacol Ther; 1999; 12(3):193-201. PubMed ID: 10419839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo administration of azithromycin affects lymphocyte activity in vitro.
    Tomazic J; Kotnik V; Wraber B
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1786-9. PubMed ID: 8239585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.